It is certainly interesting, and a bit sad. The Akerna thing is wild, and I don't see them holding on, just my take. Their entire cap is ~15M, they have what 20M is notes due soon and the current drop happened BEFORE they reminded shareholders of an upcoming split (their last press release I can find). I have to assume some really poor leadership on their behalf as well as at Forian. BioTrack, Forian's cannabis arm, has won multiple government contracts and converted some medical only into recreational markets, further expanding a foothold. Barely any mentions and zero company hype, despite what records show as positive growth at the company level. I'm holding on because of where I bought in, I'll be at a great enough loss anyway so riding for shits and giggles.
News 
Market Data 
Discover 
